Page last updated: 2024-09-03

tamsulosin and Urinary Tract Diseases

tamsulosin has been researched along with Urinary Tract Diseases in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's12 (80.00)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiu, G; Connolly, PJ; Li, S; Liu, J; Middleton, SA; Pulito, V1
Loran, OB; Seregin, AA1
Bridgeman, MB; Dalal, KS1
Wyndaele, JJ1
Chiu, B; Chuang, YC; Chung, SD; Kuo, HC1
Nickel, JC1
de la Rosette, JJ; Michel, MC1
Lowe, FC1
Busse, M; Gross, AJ; Leonard, J; Schumacher, H1
Athanasopoulos, A; Perimenis, P1
Bondarenko, B; Engelmann, U; Funk, P; Schläfke, S; Walther, C1
Baert, L; Chapple, CR; Höfner, K; Khoe, GS; Spångberg, A; Thind, P1
Jarvis, B; Lyseng-Williamson, KA; Wagstaff, AJ1
Chess-Williams, R1
Dunn, CJ; Faulds, DM; Matheson, A1

Reviews

7 review(s) available for tamsulosin and Urinary Tract Diseases

ArticleYear
The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia.
    Urology, 2003, Volume: 62, Issue:3 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prostatic Hyperplasia; Prostatitis; Radiotherapy; Sulfonamides; Tamsulosin; Urologic Diseases; Urologic Surgical Procedures

2003
Efficacy and safety of tamsulosin in the treatment of urological diseases.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Male; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urologic Diseases

2004
Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Clinical therapeutics, 2004, Volume: 26, Issue:11

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Clinical Trials as Topic; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Tract; Urologic Diseases

2004
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases

2005
Tamsulosin: an update of its role in the management of lower urinary tract symptoms.
    Drugs, 2002, Volume: 62, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urologic Diseases

2002
The use of alpha-adrenoceptor antagonists in lower urinary tract disease.
    Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:2

    Topics: Adrenergic alpha-Antagonists; Humans; Hypertension; Male; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urologic Diseases

2002
Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.
    Drugs & aging, 2002, Volume: 19, Issue:2

    Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urinary Bladder; Urologic Diseases

2002

Trials

2 trial(s) available for tamsulosin and Urinary Tract Diseases

ArticleYear
[The effectiveness and safety of Omnik OCAS in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia in the routine clinical practice in the Russian Federation (prospective multi-center observing program)].
    Urologiia (Moscow, Russia : 1999), 2018, Issue:2

    Topics: Aged; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Recovery of Function; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urologic Diseases

2018
Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin.
    Arzneimittel-Forschung, 2006, Volume: 56, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Plant Extracts; Prospective Studies; Serenoa; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urodynamics; Urologic Diseases; Urticaceae

2006

Other Studies

6 other study(ies) available for tamsulosin and Urinary Tract Diseases

ArticleYear
(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Bioorganic & medicinal chemistry letters, 2007, Jun-15, Volume: 17, Issue:12

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Binding Sites; Cloning, Molecular; Humans; Ligands; Male; Models, Chemical; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Structure-Activity Relationship; Sulfonamides; Urologic Diseases

2007
Drugs for urologic disorders.
    Nursing, 2015, Volume: 45, Issue:6

    Topics: Acetanilides; Azasteroids; Drug Combinations; Dutasteride; Ferric Compounds; Gels; Humans; Injections; Maltose; Mandelic Acids; Sulfonamides; Tamsulosin; Thiazoles; Urologic Diseases; Urological Agents

2015
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Safety; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urologic Diseases

2009
Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of
    European urology, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Antagonists; Calcinosis; Humans; Inflammation; Male; Middle Aged; Prostate; Prostatic Diseases; Prostatitis; Sulfonamides; Tamsulosin; Urinary Bladder, Overactive; Urologic Diseases

2009
Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
    Prostate cancer and prostatic diseases, 2005, Volume: 8, Issue:3

    Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Phytotherapy; Product Surveillance, Postmarketing; Prospective Studies; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Treatment Outcome; Urologic Diseases

2005
Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group.
    European urology, 1997, Volume: 32, Issue:4

    Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Pulse; Randomized Controlled Trials as Topic; Retrospective Studies; Sulfonamides; Tamsulosin; Urologic Diseases

1997